Zobrazeno 1 - 10
of 502
pro vyhledávání: ''
Autor:
T. Jeroen N. Hiltermann, Elisabeth Brouwer, Kornelis S M van der Geest, Abraham Rutgers, Riemer H. J. A. Slart, Sjoukje F. Oosting, Maria Sandovici
Publikováno v:
Annals of the Rheumatic Diseases, 81:e263. BMJ PUBLISHING GROUP
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases
Background Rheumatic and musculoskeletal immune-related adverse events (irAEs) are observed in about 10% of patients with cancer receiving checkpoint inhibitors (CPIs). Given the recent emergence of these events and the lack of guidance for rheumatol
Autor:
Antonella Frattari, Nicola Potere, Rosa Scurti, Marcello Di Nisio, Donatella Cibelli, Giustino Parruti, Antonio Abbate, Ettore Porreca
Publikováno v:
Annals of the rheumatic diseases, 81(10):e195. BMJ Publishing Group
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases
We thank Dr Buckley1 for the interest in our report on interleukin-6 receptor blockade with subcutaneous tocilizumab in patients with severe COVID-19 pneumonia receiving supplemental oxygen without mechanical ventilation and hyperinflammation.2 We ac
Autor:
Michael Bonelli, Stephan Blüml, Philipp Hofer, Leonhard X. Heinz, Stefan Winkler, Daniela Sieghart, Josef S Smolen, Marianne Graninger, Daniel Aletaha, Karin Stiasny, Helmuth Haslacher, Helga Radner, Selma Tobudic, Maximilian Koblischke, Renate Thalhammer, Thomas Perkmann, Daniel Mrak, Judith H. Aberle
Publikováno v:
Annals of the Rheumatic Diseases
ObjectivesEvidence suggests that B cell-depleting therapy with rituximab (RTX) affects humoral immune response after vaccination. It remains unclear whether RTX-treated patients can develop a humoral and T-cell-mediated immune response against SARS-C
Autor:
María Laura Acosta Felquer, Luciano LoGiudice, Enrique R. Soriano, María Laura Galimberti, Luis Daniel Mazzuoccolo, Javier Rosa
Publikováno v:
Annals of the Rheumatic Diseases. 81:74-79
ObjectivesTo compare the incidence of psoriatic arthritis (PsA) in patients with psoriasis (PsO) according to different treatments for their skin: topics/no treatment, conventional disease-modifying antirheumatic drugs (DMARDs) (cDMARDs) or biologica
Autor:
Antonio Manzo, Silvia Balduzzi, Eleonora Mauric, Laura Bogliolo, Fausto Baldanti, Terenzj Luvaro, Bernardo D’onofrio, Daniele Lilleri, Serena Bugatti, Maria Immacolata Greco, Ludovico De Stefano, Michele di Lernia, Irene Cassaniti, Iolanda Mazzucchelli, Carlomaurizio Montecucco
Publikováno v:
Annals of the Rheumatic Diseases. 80:1635-1638
Strategies aimed at expediting immunisation campaigns against COVID-19 include providing single vaccine doses to individuals with previous exposure to SARS-CoV-2 and delaying second doses. While such approaches are effective at the population level,
Autor:
Tena K. Li, Cheuk-Wan Yim, Junbin Huang, Lai-Shan Tam, Tommy Tsz-On Lam, Vincent Lo, James F. Griffith, Ho So, Isaac T Cheng, Jolie Lee, Kitty Y Kwok, Lin Shi, Vivian Wing-Yin Hung, Vivian W Y Lee, Sze-Lok Lau, Jack Lee, Ling Qin, Edmund K. Li, Evelyn Chow
Publikováno v:
Annals of the Rheumatic Diseases. 80:981-988
ObjectiveTo evaluate the effects of denosumab on erosion healing at 2–4 metacarpophalangeal (MCP) head as determined by high-resolution peripheral quantitative CT (HR-pQCT) in patients with rheumatoid arthritis (RA) with stable disease.MethodsThis
Autor:
Nirupam Purkayastha, Myles Lewis, Katriona Goldmann, W.S. Tan, Alessandra Nerviani, Stephen Kelly, Marie-Astrid Boutet, Tamás Lajtos, Costantino Pitzalis, Rebecca Hands
Publikováno v:
Annals of the Rheumatic Diseases
ObjectivesTo determine the relationship between synovial versus skin transcriptional/histological profiles in patients with active psoriatic arthritis (PsA) and explore mechanistic links between diseased tissue pathology and clinical outcomes.Methods
Autor:
Yoshihiko Sakurai, Satoshi Okada, Masato Yashiro, Nami Okamoto, Tomoko Matsuda, Hiroshi Fujii, Ryuta Nishikomori, Yuzaburo Inoue, Ikuo Okafuji, Naotomo Kambe, Yoko Ueki, Utako Kaneko, Masami Inoue, Mototsugu Doi, Naoki Kato, Nobuo Kanazawa, Hiroko Kobayashi, Junichi Hosokawa, Ichiro Kobayashi, Shuichi Ito, Syuji Takei, Kyoko Tonomura, Yasuhiro Kondo, Yoshikazu Otsubo, Atsushi Kawakami, Kazushi Izawa, Megumu K. Saito, Naomi Iwata, Teruhiko Makino, Osamu Ohara, Yuta Maruyama, Yoshitaka Honda, Shusaku Ito
Publikováno v:
Annals of the Rheumatic Diseases. 79:1492-1499
ObjectivesTo collect clinical information and NOD2 mutation data on patients with Blau syndrome and to evaluate their prognosis.MethodsFifty patients with NOD2 mutations were analysed. The activity of each NOD2 mutant was evaluated in HEK293 cells by
Autor:
Dirkjan van Schaardenburg, Ute Nonhoff, Madeleine Jenning, Vijay Joshua, Karl Skriner, Jimmy Ytterberg, Anca I. Catrina, Lotte A van de Stadt, Bianka Marklein, Thomas Häupl, Gerd R Burmester, Z. Konthur, Roman A. Zubarev
Publikováno v:
Annals of the rheumatic diseases, 79(9), 1194-1202. BMJ Publishing Group
ObjectivesPorphyromonas gingivalis (P.g.) is discussed to be involved in triggering self-reactive immune responses. The aim of this study was to investigate the autocitrullinated prokaryotic peptidylarginine deiminase (PPAD) from P.g. CH2007 (RACH200
Publikováno v:
Annals of the Rheumatic Diseases. 79:304-307
The presence of antiphospholipid antibodies (aPL) in patients with systemic lupus erythematosus (SLE) has been associated with increased risk of thrombotic and/or obstetric manifestations.1 The mechanism of action of belimumab is inhibition of the bi